These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Androgen deprivation and antagonism in the treatment of advanced prostatic carcinoma. Gibbs SJ; Plowman PN Clin Oncol (R Coll Radiol); 1996; 8(6):346-52. PubMed ID: 8973848 [No Abstract] [Full Text] [Related]
8. Progress in Understanding What Is Being Statin(ed) in Prostate Cancer. Ramos JD; Yu EY JAMA Oncol; 2015 Jul; 1(4):428-30. PubMed ID: 26181247 [No Abstract] [Full Text] [Related]
9. Measuring the effectiveness of androgen-deprivation therapy for prostate cancer in the medicare population: adequate data are neither the same as nor the enemy of perfect data. Trinh QD; Schrag D JAMA Intern Med; 2014 Sep; 174(9):1468-9. PubMed ID: 25023522 [No Abstract] [Full Text] [Related]
11. [Hormone refractory prostate cancer and the prevention of the adverse effects of the treatment]. Zgliczyński S; Borówka A Endokrynol Pol; 2005; 56(3):223. PubMed ID: 16350713 [No Abstract] [Full Text] [Related]
12. Hormonal therapies: ADT for prostate cancer: true love or heartbreak? Efstathiou JA; Shipley WU; Zietman AL; Smith MR Nat Rev Clin Oncol; 2010 Mar; 7(3):130-2. PubMed ID: 20190794 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: Say no to ADT for localized disease. Payton S Nat Rev Urol; 2014 Sep; 11(9):487. PubMed ID: 25069734 [No Abstract] [Full Text] [Related]
14. Hormonal treatment for progression. Miller K Eur J Cancer; 2009 Sep; 45 Suppl 1():158-60. PubMed ID: 19775614 [No Abstract] [Full Text] [Related]
15. [Somatostatin analogs in the combined treatment of patients with hormone-resistant prostate cancer]. Kaprin AD; Gafanov PA; Fastovets SV Vopr Onkol; 2009; 55(4):474-6. PubMed ID: 19947374 [No Abstract] [Full Text] [Related]
16. Management of the hormone sensitivity of prostate cancer: where are we now? Alcaraz A Eur Urol; 2008 Aug; 54(2):247-50; discussion 250-1. PubMed ID: 18343562 [No Abstract] [Full Text] [Related]
17. Intermittent androgen suppression. Too good to be true? Abrahamsson PA Scand J Urol Nephrol Suppl; 1999; 203():45-9. PubMed ID: 10636570 [TBL] [Abstract][Full Text] [Related]